Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 1019-1027

  Vann, R E ^a   Walentiny, D M ^a   Burston, J J ^a   Tobey, K M ^a   Gamage, T F ^a   Wiley, J L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Anandamide; Cannabinoid; CP 55940; Drug discrimination; FAAH; PMSF; THC

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; FATTY ACID AMIDASE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CANNABIS ADDICTION; CONTROLLED STUDY; ENZYME INHIBITION; LONG EVANS RAT; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR BINDING;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISCRIMINATION LEARNING; ENDOCANNABINOIDS; MALE; MICE; MICE, INBRED ICR; PHENYLMETHYLSULFONYL FLUORIDE; PROTEASE INHIBITORS; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 84855976269     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.10.011     Document Type: Article

References (54)

1. I.B. Adams, W. Ryan, M. Singer, B.F. Thomas, D.R. Compton, R.K. Razdan, and B.R. Martin Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs J. Pharmacol. Exp. Ther. 273 1995 1172 1181
2. S. Agurell, M. Halldin, J.E. Lindgren, A. Ohlsson, M. Widman, H. Gillespie, and L. Hollister Pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man Pharmacol. Rev. 38 1986 21 43
3. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neurosci. Biobehav. Rev. 16 1992 55 62
4. R.L. Barrett, J.L. Wiley, R.L. Balster, and B.R. Martin Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats Psychopharmacology (Berl) 118 1995 419 424
5. T. Bisogno, F. Berrendero, G. Ambrosino, M. Cebeira, J.A. Ramos, J.J. Fernandez-Ruiz, and V. Di Marzo Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function Biochem. Biophys. Res. Commun. 256 1999 377 380
6. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
7. C.S. Breivogel, L.J. Sim, and S.R. Childers Regional differences in cannabinoid receptor/G-protein coupling in rat brain J. Pharmacol. Exp. Ther. 282 1997 1632 1642
8. R.T. Burkey, and J.R. Nation (R)-methanandamide, but not anandamide, substitutes for delta-9-THC in a drug-discrimination procedure Exp. Clin. Psychopharmacol. 5 1997 195 202
9. D. Colquhoun Lectures on Biostatistics: An Introduction to Statistics with Applications in Biology and Medicine 1971 Clarendon Press Oxford
10. D.R. Compton, and B.R. Martin The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity J. Pharmacol. Exp. Ther. 283 1997 1138 1143
11. D.R. Compton, K.C. Rice, B.R. De Costa, R.K. Razdan, L.S. Melvin, M.R. Johnson, and B.R. Martin Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities J. Pharmacol. Exp. Ther. 265 1993 218 226
12. B.F. Cravatt, O. Prospero-Garcia, G. Siuzdak, N.B. Gilula, S.J. Henriksen, D.L. Boger, and R.A. Lerner Chemical characterization of a family of brain lipids that induce sleep Science 268 1995 1506 1509
13. E.S. Davidson, and S. Schenk Variability in subjective responses to marijuana: initial experiences of college students Addict. Behav. 19 1994 531 538
14. F. Desarnaud, H. Cadas, and D. Piomelli Anandamide amidohydrolase activity in rat brain microsomes J. Biol. Chem. 270 1995 6030 6035
15. K.W. Falenski, A.J. Thorpe, J.E. Schlosburg, B.F. Cravatt, R.A. Abdullah, T.H. Smith, D.E. Selley, A.H. Lichtman, and L.J. Sim-Selley FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta-9-tetrahydrocannabinol and anandamide administration Neuropsychopharmacology 35 2010 1775 1787
16. F.M. Filbey, J.P. Schacht, U.S. Myers, R.S. Chavez, and K.E. Hutchison Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues Neuropsychopharmacology 35 2010 967 975
17. 9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat Synapse 45 2002 131 142
18. L.H. Gold, R.L. Balster, R.L. Barrett, D.T. Britt, and B.R. Martin A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys J. Pharmacol. Exp. Ther. 262 1992 479 486
19. B.C. Haberstick, J.S. Zeiger, R.P. Corley, C.J. Hopfer, M.C. Stallings, S.H. Rhee, and J.K. Hewitt Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana use Addiction 106 2010 215 224
20. S. Hardison, S.T. Weintraub, and A. Giuffrida Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations Prostaglandins Other Lipid Mediat 81 2006 106 112
21. H.M. Haughey, E. Marshall, J.P. Schacht, A. Louis, and K.E. Hutchison Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes Addiction 103 2008 1678 1686
22. M.N. Hill, and B.S. McEwan Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 34 2010 791 797
23. T.U. Jarbe, R.J. Lamb, S. Lin, and A. Makriyannis (R)-Methanandamide and delta-9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacology (Berl) 156 2001 369 380
24. T.U. Jarbe, R.J. Lamb, Q. Liu, and A. Makriyannis (R)-Methanandamide and delta-9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A Eur. J. Pharmacol. 466 2003 121 127
25. Y. Le Strat, N. Ramoz, J. Horwood, B. Falissard, C. Hassler, L. Romo, M. Choquet, D. Fergusson, and P. Gorwood First positive reactions to cannabis constitute a priority risk factor for cannabis dependence Addiction 104 2009 1710 1717
26. A.H. Lichtman, E.G. Hawkins, G. Griffin, and B.F. Cravatt Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo J. Pharmacol. Exp. Ther. 302 2002 73 79
27. K. Mackie Signaling via CNS cannabinoid receptors Mol. Cell Endocrinol. 286 2008 S60 S65
28. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol. Biochem. Behav. 40 1991 471 478
29. L.R. McMahon, B.C. Ginsburg, and R.J. Lamb Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta-9-tetrahydrocannabinol in C57BL/6J mice Psychopharmacology (Berl) 198 2008 487 495
30. R. Mechoulam, E. Fride, L. Hanus, T. Sheskin, T. Bisogno, V. Di Marzo, M. Bayewitch, and Z. Vogel Anandamide may mediate sleep induction Nature 389 1997 25 26
31. National Research Council Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, D.C
32. E.C. Nyoni, B.R. Sitaram, and D.A. Taylor Determination of delta-9-tetrahydrocannabinol levels in brain tissue using high-performance liquid chromatography with electrochemical detection J. Chromatogr. B. Biomed. Appl. 679 1996 79 84
33. W.R. Prescott, L.H. Gold, and B.R. Martin Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta-9-THC in the rat Psychopharmacology (Berl) 107 1992 117 124
34. D. Richardson, C.A. Ortori, V. Chapman, D.A. Kendall, and D.A. Barrett Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry Anal. Biochem. 360 2007 216 226
35. 1 receptor density to G-protein activation J. Neurochem. 77 2001 1048 1057
36. 35S]thio]-triphosphate binding Proc. Natl. Acad. Sci. U.S.A. 92 1995 7242 7246
37. J.C. Sipe, K. Chiang, A.L. Gerber, E. Beutler, and B.F. Cravatt A missense mutation in human fatty acid amide hydrolase associated with problem drug use Proc. Natl. Acad. Sci. U.S.A. 99 2002 8394 8399
38. M. Solinas, G. Tanda, Z. Justinova, C.E. Wertheim, S. Yasar, D. Piomelli, S.K. Vadivel, A. Makriyannis, and S.R. Goldberg The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport J. Pharmacol. Exp. Ther. 321 2007 370 380
39. M. Solinas, G. Tanda, C.E. Wertheim, and S.R. Goldberg Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamide Psychopharmacology 209 2010 191 202
40. P.T. Speakman, and R.E. Yarwood Trypsin inhibition by phenylmethylsulphonylfluoride with reduced wool as substrate Nature 211 1966 201 202
41. P. Turini, S. Kurooka, M. Steer, A.N. Corbascio, and T.P. Singer The action of phenylmethylsulfonyl fluoride on human acetylcholinesterase, chymotrypsin and trypsin J. Pharmacol. Exp. Ther. 167 1969 98
42. R.E. Vann, J.A. Warner, K. Bushell, J.W. Huffman, B.R. Martin, and J.L. Wiley Discriminative stimulus properties of delta-9-tetrahydrocannabinol (THC) in C57Bl/6J mice Eur. J. Pharmacol. 615 2009 102 107
43. D.M. Walentiny, T.F. Gamage, J.A. Warner, T.K. Nguyen, D.B. Grainger, J.L. Wiley, and R.E. Vann The endogenous cannabinoid anandamide shares discriminative stimulus effects with delta-9-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice Eur. J. Pharmacol. 656 2011 63 67
44. 9-tetrahydrocannabinol administration in the rat Psychopharmacology 161 2002 129 136
45. J. Wiley, R. Balster, and B. Martin Discriminative stimulus effects of anandamide in rats Eur. J. Pharmacol. 276 1995 49 54
46. J.L. Wiley, R.L. Barrett, J. Lowe, R.L. Balster, and B.R. Martin Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats Neuropharmacology 34 1995 669 676
47. J.L. Wiley, M.A. Dewey, R.G. Jefferson, R.L. Winckler, D.T. Bridgen, K.A. Willoughby, and B.R. Martin Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects Life Sci. 67 2000 1573 1583
48. J.L. Wiley, K.M. Golden, W.J. Ryan, R.L. Balster, R.K. Razdan, and B.R. Martin Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys Pharmacol. Biochem. Behav. 58 1997 1139 1143
49. J.L. Wiley, K.L. LaVecchia, N.E. Karp, S. Kulasegram, A. Mahadevan, R.K. Razdan, and B.R. Martin A comparison of the discriminative stimulus effects of delta-9-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats Exp. Clin. Psychopharmacol. 12 2004 173 179
50. J.L. Wiley, and B.R. Martin Cannabinoid pharmacological properties common to other centrally acting drugs Eur. J. Pharmacol. 471 2003 185 193
51. J.L. Wiley, W.J. Ryan, R.K. Razdan, and B.R. Martin Evaluation of cannabimimetic effects of structural analogs of anandamide in rats Eur. J. Pharmacol. 355 1998 113 118
52. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
53. J.S. Zeiger, B.C. Haberstick, R.P. Corley, M.A. Ehringer, T.J. Crowley, J.K. Hewitt, C.J. Hopfer, M.C. Stallings, S.E. Young, and S.H. Rhee Subjective effects to marijuana associated with marijuana use in community and clinical subjects Drug Alcohol Depend. 109 2010 161 166
54. P.W. Zhang, H. Ishiguro, T. Ohtsuki, J. Hess, F. Carillo, D. Walther, E.S. Onaivi, T. Arinami, and G.R. Uhl Human cannabinoid receptor 1:5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse Mol. Psychiatry 9 2004 916 931